594 related articles for article (PubMed ID: 21841310)
21. Regulation of 4E-BP1 activity in the mammalian oocyte.
Jansova D; Koncicka M; Tetkova A; Cerna R; Malik R; Del Llano E; Kubelka M; Susor A
Cell Cycle; 2017 May; 16(10):927-939. PubMed ID: 28272965
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
23. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
24. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
25. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
26. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.
Sastre-Garau X; Peter M; Avril MF; Laude H; Couturier J; Rozenberg F; Almeida A; Boitier F; Carlotti A; Couturaud B; Dupin N
J Pathol; 2009 May; 218(1):48-56. PubMed ID: 19291712
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
28. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
29. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S
Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619
[TBL] [Abstract][Full Text] [Related]
30. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma.
Reisinger DM; Shiffer JD; Cognetta AB; Chang Y; Moore PS
J Am Acad Dermatol; 2010 Sep; 63(3):400-3. PubMed ID: 20584559
[TBL] [Abstract][Full Text] [Related]
31. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
33. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
34. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
Schalm SS; Fingar DC; Sabatini DM; Blenis J
Curr Biol; 2003 May; 13(10):797-806. PubMed ID: 12747827
[TBL] [Abstract][Full Text] [Related]
35. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling.
Soni A; Akcakanat A; Singh G; Luyimbazi D; Zheng Y; Kim D; Gonzalez-Angulo A; Meric-Bernstam F
Mol Cancer Ther; 2008 Jul; 7(7):1782-8. PubMed ID: 18644990
[TBL] [Abstract][Full Text] [Related]
36. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
Angermeyer S; Hesbacher S; Becker JC; Schrama D; Houben R
J Invest Dermatol; 2013 Aug; 133(8):2059-64. PubMed ID: 23439392
[TBL] [Abstract][Full Text] [Related]
37. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
Jossé L; Xie J; Proud CG; Smales CM
Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase.
Xu K; Wang L; Feng W; Feng Y; Shu HK
Oncogene; 2016 Nov; 35(44):5807-5816. PubMed ID: 27065332
[TBL] [Abstract][Full Text] [Related]
39. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
40. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1.
Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S
Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]